The cause of hairy cell leukemia (HCL) is unknown. Current treatments seem effective only for a limited period of time. In addition, a significant proportion of patients remain refractive to all treatment options. These considerations indicate the need to develop alternative therapeutic strategies for HCL. Here, we report that HCL is characterized by underexpression of RhoH. In vitro reconstitution of RhoH expression inhibits the aberrant adhesion and transendothelial migration that drives disease pathogenesis. In an in vivo model of HCL, RhoH reconstitution limits malignant progression and protects against mortality. These findings provide the proof of principle that RhoH reconstitution represents a potential new approach to the treatment of HCL. ©2008 American Association for Cancer Research.
CITATION STYLE
Galiègue-Zouitina, S., Delestré, L., Dupont, C., Troussard, X., & Shelley, C. S. (2008). Underexpression of RhoH in hairy cell leukemia. Cancer Research, 68(12), 4531–4540. https://doi.org/10.1158/0008-5472.CAN-07-5661
Mendeley helps you to discover research relevant for your work.